- Patent Title: Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
-
Application No.: US16190087Application Date: 2018-11-13
-
Publication No.: US10463653B2Publication Date: 2019-11-05
- Inventor: Lv Liao , Jing Xiong
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agency: Rimôn, P.C.
- Priority: CNPCT/CN2014/088094 20141003
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; A61K31/4545 ; A61K31/496 ; A61P35/00 ; A61K31/55
Abstract:
The present invention relates to therapeutic uses of compounds of formula (1) or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20190076412A1 USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS Public/Granted day:2019-03-14
Information query
IPC分类:
